Key Publications and White Papers

Statistical Innovation in Pharmaceuticals

Title: “Statistical Innovation in Pharmaceuticals: Observations from the Community Summit and Beyond”

Authors: Chenguang Wang (Regeneron), Satrajit Roychoudhury (Pfizer)

Key Topics:

  • Theoretical foundations of new statistical methods
  • Simulation study design and collaboration strategies
  • 21st Century Cures Act impact on medical product innovation
  • Complex Innovative Trial Design (CID) Paired Meeting Program

Regulatory Resources

FDA Programs and Initiatives

Complex Innovative Trial Design (CID) Program

  • Purpose: Foster conversations with FDA on innovative solutions
  • Application: Novel trial designs and statistical methodologies
  • Contact: FDA Office of Biostatistics

21st Century Cures Act

  • Enacted to accelerate medical product innovation
  • Promotes patient-focused drug development
  • Supports real-world evidence integration

Professional Development

Career Path Considerations

Key Questions for Innovation Statisticians:

  1. What should be the career path for innovation group members?
  2. How can they impact patients directly?
  3. How will accomplishments be recognized in organizations and the statistics field?

Essential Skills for Statistical Innovators:

  • Deep understanding of business models
  • Cross-functional collaboration abilities
  • Regulatory science knowledge
  • Communication and stakeholder management
  • Technical expertise in emerging methodologies

Training and Education

Recommended Focus Areas:

  • Estimands and target trial frameworks
  • Dose optimization methodologies
  • Combination trial designs
  • External control strategies
  • Non-proportional hazards modeling
  • Portfolio decision-making analytics
  • In silico/simulated trials
  • Machine learning integration in clinical trials

Technical Resources

Methodological Innovations

BOIN (Bayesian Optimal Interval) Design

  • Developed in collaboration with FDA
  • Phase I dose-finding methodology
  • Regulatory qualification case study

Emax Modeling for Dose-Finding

  • FDA methodology qualification experience
  • Dose-response relationship modeling
  • Regulatory acceptance pathway

Open-Source Software

Statistical Innovation Tools

  • R packages for innovative trial designs
  • Simulation frameworks
  • Regulatory submission utilities
  • Community-developed methodologies

Organizations and Communities

Professional Associations

American Statistical Association (ASA)

  • New York Metro Area Chapter - Primary summit sponsor
  • Biopharmaceutical Section - Related workshops and resources
  • Regulatory-Industry Statistics Workshop (RISW) - Annual conference

International Chinese Statistical Association (ICSA)

  • Collaborative partner organization
  • Statistical methodology advancement
  • Cross-cultural knowledge exchange

Industry Groups

Pharmaceutical Companies with Innovation Groups:

  • Regeneron Pharmaceuticals
  • Pfizer Inc.
  • Amgen
  • Eli Lilly
  • AstraZeneca
  • GSK
  • Johnson & Johnson
  • Novartis
  • Gilead Sciences
  • Astellas
  • And many others…

Upcoming Events and Opportunities

2025 Summit

Host: Pfizer Inc. Status: Planning in progress Expected Date: Fall 2025

  • Regulatory-Industry Statistics Workshop (RISW)
  • ASA Biopharmaceutical Section Workshops
  • FDA-Industry Complex Innovative Trial Design Meetings

Contact and Collaboration

How to Get Involved

For Organizations:

  • Host future summit events
  • Sponsor community initiatives
  • Share best practices and case studies
  • Participate in working groups

For Individuals:

  • Join the statistical innovation community
  • Present research and methodologies
  • Mentor junior statisticians
  • Contribute to open-source projects

Communication Channels

Email Lists:

  • Statistical Innovation Community Mailing List
  • ASA Biopharm Section Communications

Social Media:

  • Twitter: @statinnovation
  • LinkedIn: Statistical Innovation Professional Groups

GitHub:

Research and Development Priorities

Current Focus Areas

  1. Regulatory Science Advancement
    • Method qualification processes
    • Real-world evidence integration
    • Adaptive trial designs
  2. Technological Integration
    • AI/ML in clinical trials
    • Digital biomarkers
    • Electronic health records utilization
  3. Operational Excellence
    • Innovation group best practices
    • Resource allocation models
    • Success metrics development
  4. Community Building
    • Career development frameworks
    • Knowledge sharing platforms
    • Cross-industry collaboration

These resources support the continuing mission of the Statistical Innovation Community to advance pharmaceutical research and development through methodological excellence and collaborative innovation.